Ниже будет информация по компаниям которые начали (Модерна) или скоро начнут испытания вакцины от вируса. Да, это инфа старая, но она консолидирована была в одной статье и тут самые шустрые компании из представленых на бирже. Остальные представят свои вакцины в конце 2020 года. Имеет смысл на низах (напрмер $PFE) их докупить сейчас. $PFE BioNTech (BNTX) and Pfizer (PFE) Status: Human trials to begin in April The German biotech BioNTech is designing another mRNA-based Covid-19 vaccine. It plans to begin clinical trials of the vaccine in April. Outside of China, BioNTech is collaborating on the development of the vaccine with Pfizer. Inside China, the company is working with Fosun Pharma, a Chinese pharmaceutical company. $MRNA Moderna (MRNA) Status: Human trials ongoing. First patient dosed on March 16 This is perhaps the most well-known of the Covid-19 vaccine programs. Moderna, a clinical-stage biotech that develops messenger RNA-based vaccines and therapeutics, has already begun dosing patients with its experimental mRNA-based Covid-19 vaccine. Here’s an overview of the mRNA-based Covid-19 vaccine programs. $JNJ Johnson & Johnson (JNJ) Status: Human trials to begin in September Johnson & Johnson, the world’s largest pharmaceutical company, was one of the first drug developers to announce a Covid-19 vaccine program. On Monday, the company said that the vaccine could be available for emergency use early next year, and that it will start manufacturing it immediately. The company is planning to begin testing the drug in humans by September. It said Monday it planned to make the vaccine available “on a not-for-profit basis for emergency pandemic use.”